Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma

By Ostermann Kathrin   Pels Hendrik   Kowoll Annika   Kuhnhenn Jan   Schlegel Uwe  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 635-640

Springer Publishing Company

Access to resources Recommend Favorite

Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy

By Sasaki Makoto   Sugimoto Koichi   Masuda Azuchi   Tsukune Yutaka   Yahata Yuriko   Komatsu Norio  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 295-296

Springer Publishing Company

Access to resources Recommend Favorite

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

By Schmid P.   Krocker J.   Morack G.   Heilmann V.   Blohmer J.-U.   Michniewicz K.   Köhler G.   Schaller-Kranz T.   Possinger K.   Elling D.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 11, 2004-11 ,pp. : 657-663

Springer Publishing Company

Access to resources Recommend Favorite

Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma

By Fisher Barbara   Seiferheld Wendy   Schultz Christopher   DeAngelis Lisa   Nelson Diane   Schold S.   Curran W.   Mehta M.  

Journal of Neuro-Oncology, Vol. 74, Iss. 2, 2005-09 ,pp. : 201-205

Springer Publishing Company

Access to resources Recommend Favorite

Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study

By Helsing M.D.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 500-502

Elsevier

Access to resources Recommend Favorite